Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1621 1622 1623 1626
This examiner grants 76% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18282874 | METHOD FOR PREPARING ENANTIOMERICALLY ENRICHED 2-[2-(2-CHLOROTHIAZOL-5-YL)-2-HYDROXY-ETHYL]SULFANYL-6-HYDROXY-3-METHYL-5-PHENYL-PYRIMIDIN-4-ONE BY HYDROGENATION OF THE 2-OXO DERIVATIVE IN THE PRESENCE OF A CHIRAL TRANSITION METAL CATALYST | Non-Final OA | BASF SE |
| 18008648 | PREPARATION METHOD OF ACRYLONITRILE DIMER | Final Rejection | LG CHEM, LTD. |
| 17807292 | PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF | Non-Final OA | AbbVie Inc. |
| 18266688 | INHIBITORS OF NEF DOWNMODULATION | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF MICHIGAN |
| 17620103 | FUROSEMIDE ANALOGUES AND COMPOSITIONS AND USES THEREOF FOR TREATMENT OF ALZHEIMER'S DISEASE | Final Rejection | UNIVERSITY HEALTH NETWORK |
| 17635631 | ARYL AND PYRIDYL AMIDE PESTICIDES AND COMPOSITIONS THEREOF | Final Rejection | University of Florida Research Foundation, Incorporated |
| 17768152 | LPXH TARGETING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME | Final Rejection | DUKE UNIVERSITY |
| 18026877 | METHOD FOR PRODUCING SULFONATE COMPOSITION | Non-Final OA | KAO CORPORATION |
| 17774723 | Method for Preparing Heteroleptic Triarylbismuthanes and Compounds Produced by the Same | Non-Final OA | UNIVERSITY OF HAWAII |
| 17610303 | PREPARATION FOR PERCUTANEOUS ABSORPTION COMPRISING HIGH DOSE OF DONEPEZIL OR SALT THEREOF | Non-Final OA | Daewoong Pharmaceutical Co., Ltd. |
| 18564763 | FACTOR XIIA INHIBITORS | Non-Final OA | Lunac Therapeutics Ltd |
| 18476926 | LARGE SCALE SYNTHESIS OF CANNABINOL | Non-Final OA | Colorado Chromatograpy, LLC |
| 18276831 | A PROCESS FOR PREPARING NAVAFENTEROL AND INTERMEDIATES THEREOF | Non-Final OA | GBR LABORATORIES PRIVATE LIMITED |
| 18210783 | BORON CONTAINING PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM, METHODS AND USES THEREOF | Non-Final OA | BORAH, INC. |
| 18044613 | PHOSPHATIDYLALKANOL HOMOLOGUES HAVING LABELLED MOIETIES | Non-Final OA | CHIRON AS |
| 18042907 | INHIBITORS OF PSEUDOMONAS AERUGINOSA VIRULENCE FACTOR LasB | Non-Final OA | Universität Des Saarlandes |
| 18020833 | MRGPRX4 Agonists and Antagonists | Non-Final OA | Rheinische-Friedrich-Wilhelms-Universität Bonn |
| 18012364 | BRANCHED LIPID COMPOUDS | Non-Final OA | ENA Respiratory Pty Ltd |
| 17906677 | PROCESS FOR THE PREPARATION OF PROPOFOL | Final Rejection | FRESENIUS KABI ONCOLOGY LTD. |
| 17841572 | METHODS AND FORMULATIONS FOR CONTROLLING FLEA INFESTATIONS | Final Rejection | EctoGuard, LLC |
| 17770794 | TREATMENT OF EPILEPTIC CONDITIONS WITH GABAA RECEPTOR MODULATORS | Non-Final OA | NEUROCYCLE THERAPEUTICS, INC. |
| 17420756 | HtrA Inhibitors and CagA Inhibitors and Use Thereof | Non-Final OA | PSOMAGEN INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy